collection
https://read.qxmd.com/read/32989122/subarachnoid-hemorrhage-the-long-and-short-of-it
#1
REVIEW
Steven Karceski
No abstract text is available yet for this article.
September 29, 2020: Neurology
https://read.qxmd.com/read/32855422/anca-associated-vasculitis
#2
REVIEW
A Richard Kitching, Hans-Joachim Anders, Neil Basu, Elisabeth Brouwer, Jennifer Gordon, David R Jayne, Joyce Kullman, Paul A Lyons, Peter A Merkel, Caroline O S Savage, Ulrich Specks, Renate Kain
The anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitides (AAVs) are a group of disorders involving severe, systemic, small-vessel vasculitis and are characterized by the development of autoantibodies to the neutrophil proteins leukocyte proteinase 3 (PR3-ANCA) or myeloperoxidase (MPO-ANCA). The three AAV subgroups, namely granulomatosis with polyangiitis (GPA), microscopic polyangiitis and eosinophilic GPA (EGPA), are defined according to clinical features. However, genetic and other clinical findings suggest that these clinical syndromes may be better classified as PR3-positive AAV (PR3-AAV), MPO-positive AAV (MPO-AAV) and, for EGPA, by the presence or absence of ANCA (ANCA+ or ANCA- , respectively)...
August 27, 2020: Nature Reviews. Disease Primers
https://read.qxmd.com/read/32759284/pulmonary-embolism-update-on-management-and-controversies
#3
REVIEW
Lisa Duffett, Lana A Castellucci, Melissa A Forgie
Pulmonary embolism is a common and potentially fatal cardiovascular disorder that must be promptly diagnosed and treated. The diagnosis, risk assessment, and management of pulmonary embolism have evolved with a better understanding of efficient use of diagnostic and therapeutic options. The use of either clinical probability adjusted or age adjusted D-dimer interpretation has led to a reduction in diagnostic imaging to exclude pulmonary embolism. Direct oral anticoagulation therapies are safe, effective, and convenient treatments for most patients with acute venous thromboembolism, with a lower risk of bleeding than vitamin K antagonists...
August 5, 2020: BMJ: British Medical Journal
https://read.qxmd.com/read/32653403/executive-summary-of-the-2020-kdigo-diabetes-management-in-ckd-guideline-evidence-based-advances-in-monitoring-and-treatment
#4
JOURNAL ARTICLE
Ian H de Boer, M Luiza Caramori, Juliana C N Chan, Hiddo J L Heerspink, Clint Hurst, Kamlesh Khunti, Adrian Liew, Erin D Michos, Sankar D Navaneethan, Wasiu A Olowu, Tami Sadusky, Nikhil Tandon, Katherine R Tuttle, Christoph Wanner, Katy G Wilkens, Sophia Zoungas, Lyubov Lytvyn, Jonathan C Craig, David J Tunnicliffe, Martin Howell, Marcello Tonelli, Michael Cheung, Amy Earley, Peter Rossing
Improving Global Outcomes (KDIGO) Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease represents the first KDIGO guideline on this subject. The guideline comes at a time when advances in diabetes technology and therapeutics offer new options to manage the large population of patients with diabetes and chronic kidney disease (CKD) at high risk of poor health outcomes. An enlarging base of high-quality evidence from randomized clinical trials is available to evaluate important new treatments offering organ protection, such as sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists...
October 2020: Kidney International
https://read.qxmd.com/read/32102926/albumin-in-decompensated-cirrhosis-new-concepts-and-perspectives
#5
REVIEW
Mauro Bernardi, Paolo Angeli, Joan Claria, Richard Moreau, Pere Gines, Rajiv Jalan, Paolo Caraceni, Javier Fernandez, Alexander L Gerbes, Alastair J O'Brien, Jonel Trebicka, Thierry Thevenot, Vicente Arroyo
The pathophysiological background of decompensated cirrhosis is characterised by a systemic proinflammatory and pro-oxidant milieu that plays a major role in the development of multiorgan dysfunction. Such abnormality is mainly due to the systemic spread of bacteria and/or bacterial products from the gut and danger-associated molecular patterns from the diseased liver triggering the release of proinflammatory mediators by activating immune cells. The exacerbation of these processes underlies the development of acute-on-chronic liver failure...
June 2020: Gut
https://read.qxmd.com/read/32019685/systemic-autoinflammatory-diseases
#6
REVIEW
Julie Krainer, Sandra Siebenhandl, Andreas Weinhäusel
Systemic autoinflammatory diseases (SAIDs) are a growing group of disorders caused by a dysregulation of the innate immune system leading to episodes of systemic inflammation. In 1997, MEFV was the first gene identified as disease causing for Familial Mediterranean Fever, the most common hereditary SAID. In most cases, autoinflammatory diseases have a strong genetic background with mutations in single genes. Since 1997 more than 30 new genes associated with autoinflammatory diseases have been identified, affecting different parts of the innate immune system...
May 2020: Journal of Autoimmunity
https://read.qxmd.com/read/31839434/diagnosis-and-treatment-of-autoimmune-hemolytic-anemia-in-adults-recommendations-from-the-first-international-consensus-meeting
#7
REVIEW
Ulrich Jäger, Wilma Barcellini, Catherine M Broome, Morie A Gertz, Anita Hill, Quentin A Hill, Bernd Jilma, David J Kuter, Marc Michel, Marco Montillo, Alexander Röth, Sacha S Zeerleder, Sigbjørn Berentsen
Autoimmune hemolytic anemias (AIHAs) are rare and heterogeneous disorders characterized by the destruction of red blood cells through warm or cold antibodies. There is currently no licensed treatment for AIHA. Due to the paucity of clinical trials, recommendations on diagnosis and therapy have often been based on expert opinions and some national guidelines. Here we report the recommendations of the First International Consensus Group, who met with the aim to review currently available data and to provide standardized diagnostic criteria and therapeutic approaches as well as an overview of novel therapies...
May 2020: Blood Reviews
https://read.qxmd.com/read/31802270/chest-imaging-using-signs-symbols-and-naturalistic-images-a-practical-guide-for-radiologists-and-non-radiologists
#8
REVIEW
Alessandra Chiarenza, Luca Esposto Ultimo, Daniele Falsaperla, Mario Travali, Pietro Valerio Foti, Sebastiano Emanuele Torrisi, Matteo Schisano, Letizia Antonella Mauro, Gianluca Sambataro, Antonio Basile, Carlo Vancheri, Stefano Palmucci
Several imaging findings of thoracic diseases have been referred-on chest radiographs or CT scans-to signs, symbols, or naturalistic images. Most of these imaging findings include the air bronchogram sign, the air crescent sign, the arcade-like sign, the atoll sign, the cheerios sign, the crazy paving appearance, the comet-tail sign, the darkus bronchus sign, the doughnut sign, the pattern of eggshell calcifications, the feeding vessel sign, the finger-in-gloove sign, the galaxy sign, the ginkgo leaf sign, the Golden-S sign, the halo sign, the headcheese sign, the honeycombing appearance, the interface sign, the knuckle sign, the monod sign, the mosaic attenuation, the Oreo-cookie sign, the polo-mint sign, the presence of popcorn calcifications, the positive bronchus sign, the railway track appearance, the scimitar sign, the signet ring sign, the snowstorm sign, the sunburst sign, the tree-in-bud distribution, and the tram truck line appearance...
December 4, 2019: Insights Into Imaging
https://read.qxmd.com/read/31358311/anca-associated-vasculitis-core-curriculum-2020
#9
REVIEW
Duvuru Geetha, J Ashley Jefferson
Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) is a group of disorders characterized by inflammation and destruction of small- and medium-sized blood vessels and the presence of circulating ANCA. Clinical disease phenotypes include granulomatosis with polyangiitis, microscopic polyangiitis, eosinophilic granulomatosis with polyangiitis, and renal-limited vasculitis. Serologic classification of AAV into proteinase 3-ANCA disease and myeloperoxidase-ANCA disease correlates with a number of disease characteristics...
July 26, 2019: American Journal of Kidney Diseases
https://read.qxmd.com/read/31137547/dietary-and-pharmacological-treatment-of-nonalcoholic-fatty-liver-disease
#10
REVIEW
Anna Jeznach-Steinhagen, Joanna Ostrowska, Aneta Czerwonogrodzka-Senczyna, Iwona Boniecka, Urszula Shahnazaryan, Alina Kuryłowicz
Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in the developed world. Simple hepatic steatosis is mild, but the coexistence of steatohepatitis (NASH) and fibrosis increases the risk of hepatocellular carcinoma. Proper dietary and pharmacological treatment is essential for preventing NAFLD progression. The first-line treatment should include dietary intervention and increased physical activity. The diet should be based on the food pyramid, with a choice of products with low glycemic index, complex carbohydrates in the form of low-processed cereal products, vegetables, and protein-rich products...
May 20, 2019: Medicina
https://read.qxmd.com/read/31227226/physiology-and-pathophysiology-of-potassium-homeostasis-core-curriculum-2019
#11
REVIEW
Biff F Palmer, Deborah J Clegg
Total-body potassium (K+ ) content and appropriate distribution of K+ across the cell membrane is vitally important for normal cellular function. Total-body K+ content is determined by changes in excretion of K+ by the kidneys in response to intake levels. Under normal conditions, insulin and β-adrenergic tone also make important contributions in maintaining internal distribution of K+ . However, despite these homeostatic pathways, disorders of altered K+ homeostasis are common. Appreciating the pathophysiology and regulatory influences that determine the internal distribution and external balance of K+ is critical in designing effective treatments to restore K+ homeostasis...
November 2019: American Journal of Kidney Diseases
https://read.qxmd.com/read/31088853/thyroid-hormones-treatment-for-subclinical-hypothyroidism-a-clinical-practice-guideline
#12
JOURNAL ARTICLE
G E Bekkering, T Agoritsas, L Lytvyn, A F Heen, M Feller, E Moutzouri, H Abdulazeem, B Aertgeerts, D Beecher, J P Brito, P D Farhoumand, N Singh Ospina, N Rodondi, M van Driel, E Wallace, M Snel, P M Okwen, R Siemieniuk, P O Vandvik, T Kuijpers, M Vermandere
CLINICAL QUESTION: What are the benefits and harms of thyroid hormones for adults with subclinical hypothyroidism (SCH)? This guideline was triggered by a recent systematic review of randomised controlled trials, which could alter practice. CURRENT PRACTICE: Current guidelines tend to recommend thyroid hormones for adults with thyroid stimulating hormone (TSH) levels >10 mIU/L and for people with lower TSH values who are young, symptomatic, or have specific indications for prescribing...
May 14, 2019: BMJ: British Medical Journal
https://read.qxmd.com/read/31142480/diabetic-ketoacidosis-and-hyperosmolar-hyperglycemic-syndrome-review-of-acute-decompensated-diabetes-in-adult-patients
#13
REVIEW
Esra Karslioglu French, Amy C Donihi, Mary T Korytkowski
Diabetic ketoacidosis and hyperosmolar hyperglycemic syndrome (HHS) are life threatening complications that occur in patients with diabetes. In addition to timely identification of the precipitating cause, the first step in acute management of these disorders includes aggressive administration of intravenous fluids with appropriate replacement of electrolytes (primarily potassium). In patients with diabetic ketoacidosis, this is always followed by administration of insulin, usually via an intravenous insulin infusion that is continued until resolution of ketonemia, but potentially via the subcutaneous route in mild cases...
May 29, 2019: BMJ: British Medical Journal
https://read.qxmd.com/read/31009043/metformin-in-2019
#14
REVIEW
James Flory, Kasia Lipska
Metformin is the first-line pharmacologic treatment for type 2 diabetes and the most commonly prescribed drug for this condition worldwide, either alone or in combination with insulin or other glucose-lowering therapies. Metformin is a biguanide, a drug class of herbal origin that has been widely used to treat diabetes since the 1950s., Two other biguanides were withdrawn from clinical use because they caused lactic acidosis. Metformin was also taken off the US market due to concerns over lactic acidosis, but it subsequently has been proven safe and effective in lowering glucose levels and was reintroduced in 1995...
May 21, 2019: JAMA
https://read.qxmd.com/read/30910853/management-of-acute-upper-gastrointestinal-bleeding
#15
JOURNAL ARTICLE
Adrian J Stanley, Loren Laine
Upper gastrointestinal bleeding (UGIB) is a common medical emergency, with a reported mortality of 2-10%. Patients identified as being at very low risk of either needing an intervention or death can be managed as outpatients. For all other patients, intravenous fluids as needed for resuscitation and red cell transfusion at a hemoglobin threshold of 70-80 g/L are recommended. After resuscitation is initiated, proton pump inhibitors (PPIs) and the prokinetic agent erythromycin may be administered, with antibiotics and vasoactive drugs recommended in patients who have cirrhosis...
March 25, 2019: BMJ: British Medical Journal
https://read.qxmd.com/read/30846912/pharmacologic-management-of-nonalcoholic-steatohepatitis
#16
JOURNAL ARTICLE
Brent A Neuschwander-Tetri
Nonalcoholic steatohepatitis (NASH) is increasingly recognized as a major form of chronic liver disease in adults and children. Although improved dietary habits and regular exercise remain the primary recommendations for patients with or at risk of having NASH, implementing and sustaining these lifestyle changes have proven to be challenging. Pharmacologic approaches are now being evaluated to prevent the development of cirrhosis and its complications in the approximately 1% of the population of countries consuming a Western diet at risk for NASH...
October 2018: Gastroenterology & Hepatology
https://read.qxmd.com/read/30288759/hypoalbuminemia-pathogenesis-and-clinical-significance
#17
REVIEW
Peter B Soeters, Robert R Wolfe, Alan Shenkin
Hypoalbuminemia is associated with inflammation. Despite being addressed repeatedly in the literature, there is still confusion regarding its pathogenesis and clinical significance. Inflammation increases capillary permeability and escape of serum albumin, leading to expansion of interstitial space and increasing the distribution volume of albumin. The half-life of albumin has been shown to shorten, decreasing total albumin mass. These 2 factors lead to hypoalbuminemia despite increased fractional synthesis rates in plasma...
February 2019: JPEN. Journal of Parenteral and Enteral Nutrition
https://read.qxmd.com/read/30599030/proton-pump-inhibitors-review-of-reported-risks-and-controversies
#18
REVIEW
Simon Brisebois, Albert Merati, John Paul Giliberto
UNLABELLED: Proton pump inhibitors (PPIs) are among the most prescribed classes of drugs in this day and age. These may be beneficial to treat many gastrointestinal conditions, such as gastroesophageal reflux or Barrett's esophagus as well as laryngopharyngeal reflux. However, many reports have emerged in the literature exposing the potential association of PPIs with various risks and complications such as bone fracture, infection, myocardial infarction, renal disease, and dementia. This review highlights many of these potential adverse side effects by exploring relevant publications and addressing the controversies associated with those findings...
December 2018: Laryngoscope Investigative Otolaryngology
https://read.qxmd.com/read/30688869/ganciclovir-therapeutic-drug-monitoring-a-case-series
#19
JOURNAL ARTICLE
Anne-Grete Märtson, Daan Touw, Kevin Damman, Martijn Bakker, Annemieke Oude Lansink-Hartgring, Tjip van der Werf, Marjolein Knoester, Jan-Willem C Alffenaar
This paper presents three cases of immunocompromised patients for whom therapeutic drug monitoring (TDM) of ganciclovir in combination with cytomegalovirus (CMV) viral load measurement was used to guide treatment. The first patient is diagnosed with Thymoma A, the second is a heart transplant recipient and the third is an HIV positive patient. These patients were all diagnosed with CMV and treated with ganciclovir. Our case studies illustrate how TDM guided dosing can be helpful in the management of these complex cases...
January 25, 2019: Therapeutic Drug Monitoring
https://read.qxmd.com/read/30559234/8-obesity-management-for-the-treatment-of-type-2-diabetes-standards-of-medical-care-in-diabetes-2019
#20
REVIEW
(no author information available yet)
The American Diabetes Association (ADA) "Standards of Medical Care in Diabetes" includes ADA's current clinical practice recommendations and is intended to provide the components of diabetes care, general treatment goals and guidelines, and tools to evaluate quality of care. Members of the ADA Professional Practice Committee, a multidisciplinary expert committee, are responsible for updating the Standards of Care annually, or more frequently as warranted. For a detailed description of ADA standards, statements, and reports, as well as the evidence-grading system for ADA's clinical practice recommendations, please refer to the Standards of Care Introduction Readers who wish to comment on the Standards of Care are invited to do so at professional...
January 2019: Diabetes Care
label_collection
label_collection
8501
1
2
2019-01-21 14:13:23
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.